Published in Healthcare Mergers, Acquisitions and Ventures Week, May 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Nanogen.
Report 1: Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease biomarkers. The current patents are the most recent in a series describing biomarkers associated with these diseases.
U.S. Patent No. 7,179,610, "Complement C3 precursor biopolymer markers indicative of insulin resistance" and U.S. Patent...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.